Shreyas Intermediates Q3 FY26: Persistent Losses Continue as Operations Remain Minimal

The quarter witnessed a complete halt in revenue generation, with net sales dropping to zero from ₹10.37 crores in Q2 FY26, marking a 100.00% sequential decline. This development underscores the severe operational difficulties facing the Ratnagiri-based manufacturer of dyes, pigments, and pigment intermediates, which has struggled to maintain consistent production and sales momentum in recent years.

The company's operational paralysis in Q3 FY26 represents a concerning reversal from the modest revenue generation achieved in Q2 FY26 (₹10.37 crores) and Q1 FY26 (₹6.32 crores). This intermittent pattern of sales activity suggests fundamental challenges in maintaining consistent production schedules, securing raw materials, or accessing working capital necessary for sustained operations.

Financial Performance: Operational Paralysis Deepens Losses

The financial performance in Q3 FY26 paints a grim picture of a company struggling with existential operational challenges. With zero revenue generation, the company reported an operating loss (PBDIT excluding other income) of ₹0.08 crores, compared to a marginal operating profit of ₹0.07 crores in Q2 FY26. The only source of income during the quarter was other income of ₹0.12 crores, likely from interest on deposits or investments, which partially cushioned the operational losses.

The company's cost structure reveals minimal operational activity. Employee costs stood at zero in Q3 FY26, down from negligible amounts in previous quarters, suggesting either a skeletal workforce or temporary suspension of operations. Depreciation charges of ₹0.43 crores continued to burden the profit and loss statement, reflecting the company's legacy fixed asset base that generates no corresponding revenue.

On a nine-month basis for FY26 (April to December 2025), the company generated total revenues of ₹16.69 crores (₹10.37 crores in Q2 + ₹6.32 crores in Q1), resulting in a cumulative net loss of ₹0.97 crores. The intermittent nature of revenue generation—with sales only in two of the three quarters—highlights the company's inability to maintain steady production and commercial operations.

The profit before tax for Q3 FY26 stood at a loss of ₹0.39 crores, deteriorating from a loss of ₹0.24 crores in Q2 FY26. Notably, the company has not paid any taxes for multiple quarters, consistent with its loss-making status. The absence of interest costs suggests the company has minimal debt obligations, though this provides little consolation given the operational paralysis.

Operational Challenges: A Company in Survival Mode

The operational metrics reveal a company in survival mode rather than growth mode. The return on equity (ROE) stands at a deeply negative 7.84%, whilst the return on capital employed (ROCE) languishes at negative 8.32% on average. These metrics underscore the company's inability to generate positive returns for shareholders from the capital deployed in the business. The consistently negative returns indicate severe capital inefficiency and fundamental operational dysfunction.

The balance sheet as of March 2025 shows shareholder funds of ₹16.39 crores, comprising share capital of ₹74.85 crores offset by accumulated losses reflected in reserves and surplus of negative ₹58.46 crores. The erosion of shareholder value is evident, with the company having destroyed substantial capital over the years. Fixed assets stood at ₹14.61 crores, declining from ₹16.31 crores in the previous year due to depreciation without corresponding capital expenditure.

The company's working capital position shows current assets of ₹9.22 crores against current liabilities of ₹2.48 crores as of March 2025, providing some liquidity cushion. However, the utility of this liquidity is questionable given the inability to convert it into productive operations. Trade payables of ₹2.42 crores suggest limited ongoing commercial activity with suppliers.

Industry Context: Struggling in a Competitive Landscape

The commodity chemicals sector has faced headwinds from volatile raw material prices, intense competition from Chinese imports, and demand fluctuations from downstream industries. However, Shreyas Intermediates' challenges appear far more severe than typical industry pressures. Whilst peers in the sector have managed to maintain operations and generate revenues, Shreyas has experienced complete operational shutdowns in multiple quarters.

The company's five-year sales growth of 77.64% appears impressive on paper but is misleading given the extremely low base. The company generated only ₹7.00 crores in FY16 before sales collapsed to zero in subsequent years (FY17 onwards in the annual data). The recent quarters showing sales of ₹6.32 crores and ₹10.37 crores represent attempts at revival rather than sustainable growth.

The lack of consistent operations suggests challenges beyond normal industry cyclicality—potentially including working capital constraints, difficulty in sourcing raw materials, loss of key customers, or technological obsolescence of production facilities. The company's inability to maintain even minimal production levels sets it apart from healthier peers in the commodity chemicals space.

Valuation Analysis: Premium Pricing for a Distressed Asset

Despite its operational struggles, Shreyas Intermediates trades at a price-to-book value of 3.62x, representing a significant premium to its book value of ₹1.75 per share. This valuation appears disconnected from fundamental reality, as the company is loss-making with no clear path to profitability. The P/E ratio is not applicable given consistent losses, whilst the EV/EBITDA of negative 64.94x reflects the company's inability to generate positive operating cash flows.

The company's valuation assessment is classified as "RISKY" by analytical frameworks, a designation that appears generous given the operational paralysis. The stock's current price of ₹8.08 represents a 34.73% decline from its 52-week high of ₹12.38 but remains 17.10% above its 52-week low of ₹6.90, suggesting some speculative interest despite deteriorating fundamentals.

From a fair value perspective, the company's inability to generate consistent revenues and positive cash flows makes traditional valuation methodologies inapplicable. The book value of ₹1.75 per share provides a theoretical floor, though even this may be optimistic if the company is forced into liquidation, where fixed assets typically realise significantly less than book value.

Shareholding: Stable Promoter Base Amidst Operational Turmoil

The shareholding pattern reveals a stable promoter holding of 57.21% across the last five quarters, with no changes in promoter stake. The promoter group is led by Kesar Petroproducts Limited (27.59%) and Cyan Formulators Pvt. Ltd. (13.76%), along with members of the Sharma family. The absence of promoter stake increases despite the company's distressed valuation raises questions about promoter confidence in the revival prospects.

Foreign institutional investor (FII) holding stands at 8.39% as of December 2025, showing marginal sequential declines from 8.42% in September 2025 and 8.53% in June 2025. This gradual reduction, whilst small in magnitude, suggests cautious disengagement by foreign investors. Notably, mutual funds and insurance companies have zero exposure to the stock, reflecting the company's lack of appeal to institutional investors who typically avoid distressed, loss-making micro-caps.

Non-institutional investors hold 34.40% of the equity, showing marginal increases over recent quarters. This category typically includes retail investors and high-net-worth individuals, some of whom may be holding legacy positions with significant unrealised losses. The pledged shares data shows 10.03% of total shares are pledged, indicating some promoter entities have used their holdings as collateral for borrowings, which adds another layer of concern regarding financial stress.

Stock Performance: Severe Underperformance Across All Timeframes

The stock's performance has been dismal across virtually all timeframes, with consistent underperformance against the benchmark Sensex. Over the past year, Shreyas Intermediates has declined 22.75% whilst the Sensex gained 8.52%, resulting in a negative alpha of 31.27 percentage points. This underperformance extends across longer periods, with three-year returns of negative 28.31% against Sensex gains of 36.73%, representing an alpha of negative 65.04 percentage points.

Recent price action shows some volatility, with the stock gaining 12.07% over the past week and 7.45% over the past month, outperforming the Sensex during these short periods. However, these gains appear to be technical bounces from oversold levels rather than fundamental improvements. The year-to-date performance shows a decline of 16.70% against the Sensex's 3.04% fall, indicating continued weakness in 2026.

The stock's beta of 1.50 indicates it is 50% more volatile than the broader market, with volatility of 73.31% compared to the Sensex's 11.53%. This high volatility combined with negative returns creates a particularly unfavourable risk-return profile. The risk-adjusted return of negative 0.31 over the past year, compared to the Sensex's positive 0.74, underscores the poor risk-reward dynamics for investors.

Technical indicators paint a uniformly bearish picture, with the stock in a bearish trend as of February 13, 2026. The MACD shows bearish signals on both weekly and monthly timeframes, whilst Bollinger Bands indicate mildly bearish momentum. The stock trades below all major moving averages—5-day (₹7.83), 20-day (₹7.60), 50-day (₹8.73), 100-day (₹8.55), and 200-day (₹8.75)—confirming the established downtrend.

Investment Thesis: A Distressed Asset with Uncertain Revival Prospects

The investment thesis for Shreyas Intermediates is fundamentally challenged by the company's operational paralysis and consistent value destruction. The proprietary investment score of 12 out of 100 with a "STRONG SELL" rating accurately reflects the severe fundamental weaknesses. The company's below-average quality grade, flat financial trend, bearish technical indicators, and risky valuation combine to create an extremely unfavourable investment proposition.

The company's ability to generate sporadic revenues in Q1 and Q2 FY26 after prolonged periods of zero sales provides minimal encouragement, as the subsequent collapse to zero sales in Q3 FY26 demonstrates the unsustainable nature of these operational attempts. Without clarity on the reasons for operational shutdowns, the path to recovery, or management's strategic plans, investors face extreme uncertainty.

Key Strengths & Risk Factors

Outlook: What Lies Ahead